Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XOMA
3176
DELISTED
Xoma
XOMA
| $369K | ﹤0.01% |
+19,560
| New | +$367K |
|
3177
EverQuote
EVER
$949M
| $369K | ﹤0.01% |
56,748
+3,508
| +7% | +$29.6K |
|
3178
Fennec Pharmaceuticals
FENC
$335M
| $366K | ﹤0.01% |
+41,497
| New | +$345K |
|
3179
Noodles & Co
NDLS
$95.1M
| $365K | ﹤0.01% |
13,510
-131
| -1% | -$4.28K |
|
|
OMGA
3180
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $365K | ﹤0.01% |
+65,111
| New | +$509K |
|
|
MACK
3181
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $364K | ﹤0.01% |
+29,628
| New | +$370K |
|
3182
Cartesian Therapeutics
RNAC
$218M
| $364K | ﹤0.01% |
10,844
+8,851
| +444% | +$317K |
|
|
EVBN
3183
DELISTED
Evans Bancorp Inc
EVBN
| $364K | ﹤0.01% |
+14,609
| New | +$396K |
|
3184
HireQuest
HQI
$190M
| $364K | ﹤0.01% |
+13,973
| New | +$328K |
|
3185
KLX Energy Services
KLXE
$43.1M
| $363K | ﹤0.01% |
+37,285
| New | +$367K |
|
3186
Veru
VERU
$35.5M
| $361K | ﹤0.01% |
30,351
-8,117
| -21% | -$95.1K |
|
3187
Princeton Bancorp
BPRN
$283M
| $361K | ﹤0.01% |
+13,213
| New | +$373K |
|
3188
Reservoir Media
RSVR
$727M
| $360K | ﹤0.01% |
59,864
-1,317
| -2% | -$8.33K |
|
3189
BioAtla
BCAB
$5.34M
| $359K | ﹤0.01% |
2,391
+2,022
| +548% | +$348K |
|
3190
Chemung Financial Corp
CHMG
$394M
| $358K | ﹤0.01% |
+9,321
| New | +$355K |
|
3191
Mayville Engineering Co
MEC
$648M
| $356K | ﹤0.01% |
+28,577
| New | +$361K |
|
3192
Escalade
ESCA
$271M
| $355K | ﹤0.01% |
+26,565
| New | +$361K |
|
3193
Waldencast
WALD
$209M
| $354K | ﹤0.01% |
+45,804
| New | +$423K |
|
3194
First Community Corp
FCCO
$327M
| $354K | ﹤0.01% |
+20,379
| New | +$374K |
|
3195
Cue Biopharma
CUE
$118M
| $351K | ﹤0.01% |
3,203
+2,334
| +269% | +$274K |
|
3196
Southland Holdings
SLND
$31.7M
| $350K | ﹤0.01% |
+42,669
| New | +$349K |
|
|
LSEA
3197
DELISTED
Landsea Homes
LSEA
| $348K | ﹤0.01% |
37,275
+9,543
| +34% | +$66.8K |
|
|
HSHP
3198
Himalaya Shipping
HSHP
$689M
| $348K | ﹤0.01% |
+62,592
| New | +$355K |
|
3199
STMicroelectronics
STM
$43.1B
| $345K | ﹤0.01% |
6,902
+1,729
| +33% | +$80.2K |
|
|
ESSA
3200
DELISTED
ESSA Bancorp
ESSA
| $345K | ﹤0.01% |
+23,046
| New | +$348K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.